Cargando…

Rosiglitazone treatment restores renal responsiveness to atrial natriuretic peptide in rats with congestive heart failure

The thiazolidinedione (TZD) class of Peroxisome proliferator‐activated receptor gamma agonists has restricted clinical use for diabetes mellitus due to fluid retention and potential cardiovascular risks. These side effects are attributed in part to direct salt‐retaining effect of TZDs at the renal c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Goltsman, Ilia, Khoury, Emad E., Aronson, Doron, Nativ, Omri, Feuerstein, Giora Z., Winaver, Joseph, Abassi, Zaid
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6584517/ https://www.ncbi.nlm.nih.gov/pubmed/31087547 http://dx.doi.org/10.1111/jcmm.14366

Ejemplares similares

Rosiglitazone improves the natriuretic response to atrial natriuretic peptide in rats with experimental congestive heart failure: possible involvement of a post-guanylate cyclase mechanism
por: Goltsman, Ilia, et al.
Publicado: (2011)

Aortocaval Fistula in Rat: A Unique Model of Volume-Overload Congestive Heart Failure and Cardiac Hypertrophy
por: Abassi, Zaid, et al.
Publicado: (2011)

Edema formation in congestive heart failure and the underlying mechanisms
por: Abassi, Zaid, et al.
Publicado: (2022)

Renal effects of a novel endogenous natriuretic agent xanthurenic acid 8-o-β-d-glucoside in rats
por: Hoffman, Aaron, et al.
Publicado: (2013)

Natriuretic peptides system in the pulmonary tissue of rats with heart failure: potential involvement in lung edema and inflammation
por: Khoury, Emad E., et al.
Publicado: (2018)

Effects of Angiotensin 1-7 and Mas Receptor Agonist on Renal System in a Rat Model of Heart Failure
por: Cohen-Segev, Ravit, et al.
Publicado: (2023)

Involvement of Cytokines in the Pathogenesis of Salt and Water Imbalance in Congestive Heart Failure
por: Azzam, Zaher S., et al.
Publicado: (2017)

Distribution of Cardiac and Renal Corin and Proprotein Convertase Subtilisin/Kexin-6 in the Experimental Model of Cardio-Renal Syndrome of Various Severities
por: Khoury, Emad E., et al.
Publicado: (2021)

Plasma atrial natriuretic peptide and N-terminal pro B-type natriuretic peptide concentrations in dogs with right-sided congestive heart failure
por: KANNO, Nobuyuki, et al.
Publicado: (2015)

Natriuretic Peptides as Biomarkers for Congestive States: The Cardiorenal Divergence
por: Koratala, Abhilash, et al.
Publicado: (2017)

Interpretation and Use of Natriuretic Peptides in Non-Congestive Heart Failure Settings
por: Tsai, Shih-Hung, et al.
Publicado: (2010)

Potential Early Predictors for Outcomes of Experimental Hemorrhagic Shock Induced by Uncontrolled Internal Bleeding in Rats
por: Abassi, Zaid A., et al.
Publicado: (2013)

Cardiac congestion assessed by natriuretic peptides oversimplifies the definition and treatment of heart failure
por: Palazzuoli, Alberto, et al.
Publicado: (2021)

Correlation of natriuretic peptides and inferior vena cava size in patients with congestive heart failure
por: Hebl, Virginia, et al.
Publicado: (2012)

Great Tool or Gold Standard? B-Type Natriuretic Peptide and Congestive Heart Failure
por: Montez, Jeremy, et al.
Publicado: (2011)

Atrial Natriuretic Peptide and Adiponectin Interactions in Man
por: Birkenfeld, Andreas L., et al.
Publicado: (2012)

Natriuretic peptides for the detection of paroxysmal atrial fibrillation
por: Seegers, Joachim, et al.
Publicado: (2015)

Awareness of atrial fibrogenesis and natriuretic peptide release
por: Meijers, W. C. F. W., et al.
Publicado: (2017)

Inverse association of long-acting natriuretic peptide with metabolic syndrome in congestive heart failure patients
por: Wang, Ji-Hung, et al.
Publicado: (2013)

Recombinant human brain natriuretic peptide ameliorates venous return function in congestive heart failure
por: Luo, Jing‐chao, et al.
Publicado: (2022)

Treatment patterns of patients with acute heart failure who develop acute kidney injury
por: Boulos, Jubran, et al.
Publicado: (2018)

Efficacy of exogenous atrial natriuretic peptide in patients with heart failure with preserved ejection fraction: deficiency of atrial natriuretic peptide and replacement therapy
por: Matsumoto, Shingo, et al.
Publicado: (2020)

Exenatide infusion decreases atrial natriuretic peptide levels by reducing cardiac filling pressures in type 2 diabetes patients with decompensated congestive heart failure
por: Nathanson, David, et al.
Publicado: (2016)

Atrial natriuretic peptide and leptin interactions in healthy men
por: Daniels, Martin A., et al.
Publicado: (2023)

Hyperbaric oxygen treatment improves GFR in rats with ischaemia/reperfusion renal injury: a possible role for the antioxidant/oxidant balance in the ischaemic kidney
por: Rubinstein, Irit, et al.
Publicado: (2009)

Ratio of preoperative atrial natriuretic peptide to brain natriuretic peptide predicts the outcome of the maze procedure in mitral valve disease
por: Sato, Masafumi, et al.
Publicado: (2013)

Is Atrial Natriuretic Peptide (ANP) and Natriuretic Peptide Receptor-A (NPR-A) Expression in Human Placenta and Decidua Normal?
por: Tan, Hongchuan, et al.
Publicado: (2019)

Characteristics of acute congestive heart failure with normal ejection fraction and less elevated B-type natriuretic peptide
por: Shimamoto, Ken, et al.
Publicado: (2009)

Correlation between B-Type Natriuretic Peptide and Functional/Cognitive Parameters in Discharged Congestive Heart Failure Patients
por: Leto, Laura, et al.
Publicado: (2015)

Atrial Natriuretic Peptide Induces Postprandial Lipid Oxidation in Humans
por: Birkenfeld, Andreas L., et al.
Publicado: (2008)

N-terminal Pro-Brain Natriuretic Peptide And Atrial Fibrillation
por: Thejus, Jayachandran, et al.
Publicado: (2009)

Atrial Natriuretic Peptide in Young and Elderly Children with Mild Gastroenteritis
por: Klar, A., et al.
Publicado: (2009)

Effect of liraglutide on atrial natriuretic peptide, adrenomedullin, and copeptin in PCOS
por: Frøssing, Signe, et al.
Publicado: (2017)

Effect of Pancreatic Hormones on pro-Atrial Natriuretic Peptide in Humans
por: Zois, Nora E., et al.
Publicado: (2017)

Clinical Applications of Natriuretic Peptides in Heart Failure and Atrial Fibrillation
por: Baba, Masako, et al.
Publicado: (2019)

Pseudomonas aeruginosa Biofilm Dispersion by the Human Atrial Natriuretic Peptide
por: Louis, Mélissande, et al.
Publicado: (2022)

Associations of atrial natriuretic peptide with measures of insulin and adipose depots
por: Couch, Catharine A., et al.
Publicado: (2023)

Midregional pro-atrial natriuretic peptide, an important member of the natriuretic peptide family: potential role in diagnosis and prognosis of cardiovascular disease
por: Idzikowska, Karolina, et al.
Publicado: (2018)

Atrial Natriuretic Peptide Single Nucleotide Polymorphisms in Patients with Nonfamilial Structural Atrial Fibrillation
por: Francia, Pietro, et al.
Publicado: (2013)

Inverse Association of N-Terminal Pro-B-Type Natriuretic Peptide with Metabolic Syndrome in Patients with Congestive Heart Failure
por: Chang, Huai-Ren, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_hh91pm3q72r109u3qv40tiu257